Beth C. Seidenberg

Insider Reports History

Entity
Individual
Signature
/s/ Joseph R. Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Beth C. Seidenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Director Series A Common Stock 1.9M $7.79M $4.10 Jul 18, 2023 Indirect
Progyny, Inc. Director Common Stock 228K $7.28M $31.95 May 23, 2024 Indirect
Vera Therapeutics, Inc. Director Class A Common Stock 132K $6.52M $49.54 Oct 28, 2024 Direct
Progyny, Inc. Director Common Stock 43.4K $1.39M $31.95 May 23, 2024 Direct
Sagimet Biosciences Inc. Director Series A Common Stock 84.8K $348K $4.10 Jul 18, 2023 Direct
Vera Therapeutics, Inc. Director Class A Common Stock 4.01K $199K $49.54 Oct 28, 2024 Indirect
Sagimet Biosciences Inc. Director Series A Common Stock 46.9K $192K $4.10 Jul 18, 2023 By trust
Atara Biotherapeutics, Inc. Director Common Stock 116K $45K $0.39 May 31, 2023 Direct
Atara Biotherapeutics, Inc. Director Common Stock 197 $76.60 $0.39 May 31, 2023 Indirect
Kyverna Therapeutics, Inc. Director, 10%+ Owner Common Stock 736K Feb 12, 2024 Indirect
ACELYRIN, Inc. Director Director Stock Option (right to buy) 92.2K Jun 7, 2024 Direct
Atara Biotherapeutics, Inc. Director Non-Qualified Stock Option (Right to Buy) 79.5K May 31, 2023 Direct
Sagimet Biosciences Inc. Director Stock Option (Right to Buy) 51.5K Jun 5, 2024 Direct
Progyny, Inc. Director Stock Option (Right to Buy) 26.9K May 23, 2024 Direct
Vera Therapeutics, Inc. Director Stock Option (right to buy) 14K May 15, 2024 Direct
Kyverna Therapeutics, Inc. Director, 10%+ Owner Series A-1 Redeemable Convertible Preferred Stock 0 Feb 12, 2024 Indirect
Kyverna Therapeutics, Inc. Director, 10%+ Owner Series A-2 Redeemable Convertible Preferred Stock 0 Feb 12, 2024 Indirect
Kyverna Therapeutics, Inc. Director, 10%+ Owner Series B Redeemable Convertible Preferred Stock 0 Feb 12, 2024 Indirect
Sagimet Biosciences Inc. Director Common Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series A Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series B-1 Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series B Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series C Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series D Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series E Preferred Stock 0 Jul 18, 2023 Direct
Sagimet Biosciences Inc. Director Series E Preferred Stock 0 Jul 18, 2023 Indirect
Sagimet Biosciences Inc. Director Series F Preferred Stock 0 Jul 18, 2023 Indirect

Insider Reports Filed by Beth C. Seidenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERA Vera Therapeutics, Inc. Oct 28, 2024 2 -$720K 4 Oct 30, 2024 Director
VERA Vera Therapeutics, Inc. Sep 18, 2024 3 -$696K 4 Sep 20, 2024 Director
SLRN ACELYRIN, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
SGMT Sagimet Biosciences Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
PGNY Progyny, Inc. May 23, 2024 2 $0 4 May 28, 2024 Director
VERA Vera Therapeutics, Inc. May 15, 2024 1 $0 4 May 17, 2024 Director
KYTX Kyverna Therapeutics, Inc. Feb 12, 2024 6 $0 4 Feb 14, 2024 Director, 10%+ Owner
KYTX Kyverna Therapeutics, Inc. Feb 7, 2024 0 $0 3 Feb 7, 2024 Director, 10%+ Owner
SGMT Sagimet Biosciences Inc. Jul 18, 2023 15 $750K 4 Jul 20, 2023 Director
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 Director
PGNY Progyny, Inc. Jun 23, 2023 2 $0 4 Jun 27, 2023 Director
PGNY Progyny, Inc. Jun 9, 2023 4 $0 4 Jun 13, 2023 Director
ATRA Atara Biotherapeutics, Inc. May 31, 2023 2 $0 4 Jun 2, 2023 Director
PGNY Progyny, Inc. May 24, 2023 3 $65K 4 Jun 1, 2023 Director
VERA Vera Therapeutics, Inc. May 10, 2023 1 $0 4 May 12, 2023 Director
SLRN ACELYRIN, Inc. May 9, 2023 8 $23.6M 4 May 11, 2023 Director, 10%+ Owner
SLRN ACELYRIN, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director, 10%+ Owner
SLRN ACELYRIN, Inc. May 4, 2023 0 $0 3 May 4, 2023 Director, 10%+ Owner
VERA Vera Therapeutics, Inc. Mar 30, 2023 1 $16.7K 4 Apr 3, 2023 Director
VERA Vera Therapeutics, Inc. Mar 28, 2023 1 $173K 4 Mar 30, 2023 Director
VERA Vera Therapeutics, Inc. Mar 24, 2023 2 $25.1K 4 Mar 28, 2023 Director
VERA Vera Therapeutics, Inc. Mar 17, 2023 2 $637K 4 Mar 21, 2023 Director
VERA Vera Therapeutics, Inc. Mar 15, 2023 2 $660K 4 Mar 17, 2023 Director
VERA Vera Therapeutics, Inc. Mar 10, 2023 1 $343K 4 Mar 14, 2023 Director
VERA Vera Therapeutics, Inc. Mar 3, 2023 1 $7.25K 4 Mar 7, 2023 Director
VERA Vera Therapeutics, Inc. Mar 1, 2023 2 $170K 4 Mar 3, 2023 Director
VERA Vera Therapeutics, Inc. Feb 23, 2023 1 $1.45K 4 Feb 27, 2023 Director
VERA Vera Therapeutics, Inc. Feb 13, 2023 1 $72.5K 4 Feb 15, 2023 Director
VERA Vera Therapeutics, Inc. Feb 9, 2023 1 $2.9K 4 Feb 13, 2023 Director
VERA Vera Therapeutics, Inc. Feb 3, 2023 4 $2.21M 4 Feb 9, 2023 Director
PGNY Progyny, Inc. Oct 24, 2022 5 $0 4 Oct 26, 2022 Director
ATRA Atara Biotherapeutics, Inc. Jun 23, 2022 2 $0 4 Jun 27, 2022 Director
VERA Vera Therapeutics, Inc. May 24, 2022 1 $0 4 May 26, 2022 Director
PGNY Progyny, Inc. Dec 22, 2021 2 $0 4 Dec 27, 2021 Director
PGNY Progyny, Inc. Nov 17, 2021 4 $0 4 Nov 18, 2021 Director
PGNY Progyny, Inc. Sep 16, 2021 4 $0 4 Oct 26, 2021 Director
PGNY Progyny, Inc. Jul 19, 2021 2 $0 4 Jul 21, 2021 Director
PGNY Progyny, Inc. Jun 21, 2021 6 $0 4 Jun 23, 2021 Director
ATRA Atara Biotherapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 9, 2021 Director
VERA Vera Therapeutics, Inc. May 18, 2021 6 $0 4 May 18, 2021 Director
VERA Vera Therapeutics, Inc. May 13, 2021 1 $0 4 May 17, 2021 Director
VERA Vera Therapeutics, Inc. May 13, 2021 0 $0 3 May 13, 2021 Director